Discover how BASF's Kollidon®, Kolliphor®, and Soluplus® excipients, together with a broad range of active pharmaceutical ingredients (APIs), help you formulate safe, effective oral, topical, and parenteral dosage forms.
About BASF Pharma Solutions - a global partner in pharmaceutical ingredient supply
BASF Pharma Solutions manufactures excipients and active pharmaceutical ingredients (APIs) for pharmaceutical and nutraceutical manufacturers worldwide. With over 150 years of chemistry expertise, its portfolio spans five platforms: orals, topicals, parenterals, solubilisation, and biopharma ingredients. BASF is among the world's leading producers of APIs such as ibuprofen and omega-3 fatty acids.
Through its partnership with IMCD, BASF's ingredient portfolio is supported by local technical expertise, application guidance, and regulatory documentation across pharmaceutical markets, helping formulators access the right materials at every stage of development.
Manufacturing quality and formulation expertise you can build on
BASF's excipients are produced in GMP-compliant facilities with consistent quality and batch-to-batch reliability, a requirement for regulated drug manufacturing. Select grades are further differentiated by controlled endotoxin levels or documented nitrite testing, giving formulators additional assurance when working with oxygen- or endotoxin-sensitive active ingredients. This manufacturing rigour, combined with decades of polymer and excipient science, underpins BASF's role as a long-standing ingredient supplier to the pharmaceutical industry.
BASF is meeting formulation and manufacturing trends in pharmaceutical development
Manufacturers are increasingly formulating for poorly soluble active ingredients, a challenge addressed by BASF solubilisers such as Kolliphor® and Soluplus® that improve dissolution and bioavailability. At the same time, demand for simplified, robust manufacturing processes is driving adoption of coprocessed excipients that reduce the number of unit operations and raw materials required.
Regulatory scrutiny around impurities, including nitrites and endotoxins, is also shaping excipient selection, with documented, tested grades helping formulators streamline qualification and reduce development risk.
Typical applications across oral, topical, and parenteral dosage forms
BASF's excipients and APIs support formulation across multiple dosage forms and administration routes, including:
- Film-coated tablets
- Different production technology for tabletting
- Modified-release portfolio tablet matrix and coating
- Solubilised oral and parenteral formulations
- Amorphous solid dispersions and transdermal films
- Suppository formulations
Discover BASF’s core categories and portfolio for drug delivery
BASF's pharmaceutical portfolio combines high-quality active pharmaceutical ingredients (APIs) and innovative excipients that support formulation, manufacturing, and drug delivery across oral, topical, parenteral, and biopharmaceutical applications. Explore the key product families and their typical uses below.
Active Pharmaceutical Ingredients (APIs)
High-quality APIs supporting a wide range of pharmaceutical applications and therapeutic areas.
Coprocessed Excipients & Ready-to-Use Solutions
Designed to simplify formulation development, reduce manufacturing complexity, and improve process efficiency through integrated excipient systems.
| Key products | Typical applications |
|
|
Excipients for Oral Drug Delivery
Enabling efficient tablet and capsule formulation through binders, disintegrants, coating polymers, solubilisers, and bioavailability-enhancing excipients.
| Key products | Typical applications |
|
|
Excipients for Topical, Parenteral & Advanced Drug Delivery
Supporting topical, injectable, biopharmaceutical, and lipid-based formulations, as well as efficient pharmaceutical manufacturing processes.
| Key products | Typical applications |
|
|
IMCD & BASF: Technical collaboration and local support for your formulation challenges
IMCD supports material selection, formulation troubleshooting, and regulatory documentation, helping customers move from early-stage development to commercial-scale production. This collaboration gives formulators access to both BASF's ingredient science and IMCD's local application expertise across pharmaceutical markets worldwide.
Discover recent trend articles:
- BASF’s Holistic Approach to Nitrosamine Mitigation
- Formulating success: How excipient providers are enabling advanced GLP-1 therapies
- Industrial biotechnology: Enabling sustainable and scalable biopharmaceutical manufacturing
- United for safety - Navigating innovation with nitrosamine risks
Additionally, at IMCD Pharmaceuticals, our global network of state-of-the-art laboratory facilities and technical experts collaborate closely with partners such as BASF to develop innovative concepts and dosage forms that meet today’s evolving customer expectations.
Discover our IMCD solutions with BASF ingredients:
- Apixaban 5mg coated tablet including Kollicoat IR (speciality) and Kolliphor SLS Fine (standard)
- Apremilast Ointment including Kollisolv PG, Kollisolv PEG 400, and KOLLIPHOR CS 20
- Caffeine SR effervescent tablet including KOLLIDON 30
- Ginkgo coated tablet including KOLLICOAT IR
- Terbinafine film-forming solution including KOLLISOLOV GTA
Explore BASF pharmaceutical excipient and API solutions
You want to learn more about this partnership and the BASF Pharma Solutions portfolio? Fill in the form, and one of our experts will get in touch with you!
| Key products | Typical applications |
|
|
